Imodium, Imodium AD, Kaopectate III, Maalox Anti-diarrheal, Pepto Diarrhea Control
Classifications: gastrointestinal agent; antidiarrheal
Prototype: Diphenoxylate HCl with atropine sulfate
Pregnancy Category: B
Assessment & Drug Effects
- Monitor therapeutic effectiveness. Chronic diarrhea usually responds within 10 d. If improvement does not occur within this time, it is unlikely that symptoms will be controlled by further administration.
- Discontinue if there is no improvement after 48 h of therapy for acute diarrhea.
- Monitor fluid and electrolyte balance.
- Notify physician promptly if the patient with ulcerative colitis develops abdominal distention or other GI symptoms (possible signs of potentially fatal toxic megacolon).
Patient & Family Education
- Notify physician if diarrhea does not stop in a few days or if abdominal pain, distension, or fever develops.
- Record number and consistency of stools.
- Do not drive or engage in other potentially hazardous activities until response to drug is known.
- Do not take alcohol and other CNS depressants concomitantly unless otherwise advised by physician; may enhance drowsiness.
- Learn measures to relieve dry mouth; rinse mouth frequently with water, suck hard candy.
- Do not breast feed while taking this drug without consulting physician.